PRDM1 and sarcoidosis: Additionally, CD4+ T cells from sarcoidosis patients exhibited increased PRDM1 and GATA3 expression, while naive markers SELL, TCF7 and LEF1 were reduced in sarcoidosis and active TU compared with healthy donors (Figure 2m).